A gene ther­a­py biotech is burst­ing on­to the scene with 12 pro­grams in tow. An ul­tra-rare neu­ro dis­ease is up first

4 years ago
Financing
Startups

Em­ploy­ees in Flori­da IBS tri­al plead guilty for fal­si­fy­ing med­ical records; Cys­tic fi­bro­sis tablet Trikaf­ta now ...

4 years ago
News Briefing

Vi­a­Cyte adds to the war chest in what looks like an IPO-bound ef­fort to bring re­gen­er­a­tive med­i­cine to di­a­betes

4 years ago
Financing
Cell/Gene Tx

Flag­ship and Khosla Ven­tures team up for biotech's lat­est SPAC, with Va­lo Health win­ning a blank check tick­et to ...

4 years ago
Financing
Deals

Roivan­t's da­ta spin­out merges with ri­val in $7B deal

4 years ago
Deals

BeiGene dives in on nat­ur­al killer cells with dis­cov­ery pact for small biotech's stem cell-based plat­form

4 years ago
Deals

With its eyes set on an IPO raise, In­Car­da un­rolls mid-stage da­ta back­ing in­haled ar­rhyth­mia drug

4 years ago
R&D

Po­laris, Ab­b­Vie, Bay­er back Stu­art Schreiber's hunt to turn can­cer treat­ments in­to cures

4 years ago
Financing
Startups

Pfiz­er rolls out next-gen pneu­mo­coc­cal vac­cine with FDA win, beat­ing Mer­ck­'s 15-va­lent can­di­date to the punch

4 years ago
FDA+

Ad­comm mem­ber who warned about risk of ap­prov­ing Bio­gen's ad­u­canum­ab has re­signed fol­low­ing his­toric OK — re­ports

4 years ago
People
FDA+

US to shell out $1.2B for sup­plies of Mer­ck­'s po­ten­tial Covid-19 an­tivi­ral

4 years ago
R&D
Coronavirus

Covid-19 roundup: Phar­ma­cist who tam­pered with Mod­er­na vac­cines sen­tenced to 3 years in jail; FDA says J&J shelf life ...

4 years ago
Coronavirus

On a con­tin­ued hunt for Parkin­son's break­throughs, Ab­b­Vie turns to a biotech in its port­fo­lio

4 years ago
Deals

In­cyte faces de­lay on FDA's Jakafi de­ci­sion for cGVHD; Bay­er's Parkin­son's cell ther­a­py en­ters the clin­ic

5 years ago
News Briefing

An­a­lysts hound Bio­gen with ques­tions over Aduhelm's $56K price point as news of Alzheimer's OK rip­ples through glob­al ...

5 years ago
Pharma

Covid-19 vac­cines for kids: FDA spells out ques­tions on im­muno­bridg­ing, safe­ty fol­lowup ahead of ad­comm

5 years ago
FDA+
Coronavirus

FDA re­jects Google's push to add vir­tu­al ex­am for Parkin­son’s dis­ease to its smart­watch

5 years ago
Pharma
FDA+

End­points News poll: Let's get your opin­ion on that con­tro­ver­sial ad­u­canum­ab ap­proval

5 years ago
Pharma

Keen to turn a new page, In­di­v­ior branch­es out, pick­ing up an op­tion for cannabis ad­dic­tion drug

5 years ago
Deals

Trail­ing the Big Phar­ma play­ers, a less­er known BC­MA CAR-T can­di­date comes in­to the spot­light

5 years ago
R&D
China

Covid-19 roundup: Cure­Vac vac­cine now not ex­pect­ed be­fore Au­gust — re­port; A Covid-19 vac­cine tri­al in Africa is ...

5 years ago
Coronavirus

Hop­ing to chal­lenge block­buster breast can­cer fran­chis­es, a small Dutch biotech says its ADC passed a PhI­II test

5 years ago
R&D

White House lays out sprawl­ing new plan to shore up phar­ma and API man­u­fac­tur­ing

5 years ago
FDA+

Just how sad­ly mis­guid­ed is the FDA on ad­u­canum­ab?

5 years ago
Bioregnum
First page Previous page 692693694695696697698 Next page Last page
A service from the Financial Times